MedPath

Mitomycin

MITOMYCIN FOR INJECTION USP, 5 mg/vial NOVAPLUS

Approved
Approval ID

cef5026c-8bc3-4428-a178-6effff4dcb3f

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Sep 21, 2023

Manufacturers
FDA

Archis Pharma LLC

DUNS: 026836212

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Mitomycin

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code72819-152
Application NumberANDA202670
Product Classification
M
Marketing Category
C73584
G
Generic Name
Mitomycin
Product Specifications
Route of AdministrationINTRAVENOUS
Effective DateSeptember 21, 2023
FDA Product Classification

INGREDIENTS (2)

MITOMYCINActive
Quantity: 5 mg in 10 mL
Code: 50SG953SK6
Classification: ACTIB
MANNITOLInactive
Code: 3OWL53L36A
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Mitomycin - FDA Drug Approval Details